Showing 1 - 6 results of 6 for search 'Dwan‐Ying Chang', query time: 0.04s
Refine Results
-
1
-
2
Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis by Shang‐Hsuan Peng, Ching‐Hung Lin, I‐Chun Chen, Ying‐Chun Shen, Dwan‐Ying Chang, Tom Wei‐Wu Chen, Shu‐Min Huang, Fu‐Chang Hu, Yen‐Shen Lu
Published 2023-10-01
Article -
3
Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐... by Ming‐Han Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, Po‐Hsiang Huang, I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu
Published 2024-07-01
Article -
4
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women by Meng-shan Tsai, Shu-Han Chang, Wen-Hung Kuo, Ching-Hua Kuo, Szu-Yi Li, Ming-Yang Wang, Dwan-Ying Chang, Yen-Shen Lu, Chiun-Sheng Huang, Ann-Lii Cheng, Ching-Hung Lin, Pau-Chung Chen
Published 2020-09-01
Article -
5
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country. by Ching-Hung Lin, Chen-Yang Shen, Jih-Hsiang Lee, Chiun-Sheng Huang, Chih-Hsin Yang, Wen-Hung Kuo, Dwan-Ying Chang, Chia-Ni Hsiung, Kuan-Ting Kuo, Wei-Wu Chen, I-Chun Chen, Pei-Fang Wu, Sung-Hsin Kuo, Chien-Jen Chen, Yen-Shen Lu, Ann-Lii Cheng
Published 2015-01-01
Article -
6
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer by Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, Naohito Yamamoto, Chi-Feng Chung, Yen-Shen Lu, Dwan-Ying Chang, Joohyuk Sohn, Gun Min Kim, Kyung-Hun Lee, Soo-Chin Lee, Tsutomu Iwasa, Hiroji Iwata, Kenichi Watanabe, Kyung Hae Jung, Yuko Tanabe, Seok Yun Kang, Hiroyuki Yasojima, Kenjiro Aogi, Eriko Tokunaga, Sung Hoon Sim, Yoon Sim Yap, Koji Matsumoto, Ling-Ming Tseng, Yoshiko Umeyama, Kazuki Sudo, Yuki Kojima, Tomomi Hata, Aya Kuchiba, Taro Shibata, Kenichi Nakamura, Yasuhiro Fujiwara, Kenji Tamura, Kan Yonemori
Published 2024-08-01
Article